ZA985818B - Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders. - Google Patents

Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders.

Info

Publication number
ZA985818B
ZA985818B ZA9805818A ZA985818A ZA985818B ZA 985818 B ZA985818 B ZA 985818B ZA 9805818 A ZA9805818 A ZA 9805818A ZA 985818 A ZA985818 A ZA 985818A ZA 985818 B ZA985818 B ZA 985818B
Authority
ZA
South Africa
Prior art keywords
imidazopyrimidines
imidazopyridines
treatment
neurological disorders
neurological
Prior art date
Application number
ZA9805818A
Inventor
Richard G Wilde
Rajagopal Bakthavatchalam
James P Beck
Argyrios G Arvanitis
Original Assignee
Du Pont Merck Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Merck Pharma filed Critical Du Pont Merck Pharma
Publication of ZA985818B publication Critical patent/ZA985818B/en

Links

ZA9805818A 1997-07-03 1998-07-02 Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders. ZA985818B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5162897P 1997-07-03 1997-07-03

Publications (1)

Publication Number Publication Date
ZA985818B true ZA985818B (en) 2000-01-10

Family

ID=21972451

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9805818A ZA985818B (en) 1997-07-03 1998-07-02 Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders.

Country Status (3)

Country Link
RU (1) RU2201929C2 (en)
UA (1) UA62972C2 (en)
ZA (1) ZA985818B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0208357A (en) 2001-03-13 2004-06-29 Bristol Myers Squibb Pharma Co Compound, pharmaceutical composition, corticotropin-releasing factor (crf) receptor antagonization method, dysfunction treatment method, ligand screening method, crf receptor detection method, crf binding inhibition method, article industrialized and uses of compost
TW200911803A (en) * 2007-07-16 2009-03-16 Organon Nv 6-phenyl-1H-imidazo [4,5-c] pyridine-4-carbonitrile derivatives
CN105579453B (en) * 2013-09-26 2017-12-22 豪夫迈·罗氏有限公司 The amine of imidazo [1,2 a] pyridine 7 as imaging tool

Also Published As

Publication number Publication date
UA62972C2 (en) 2004-01-15
RU2201929C2 (en) 2003-04-10

Similar Documents

Publication Publication Date Title
IL133800A0 (en) Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders
AUPM864894A0 (en) Treatment of bowel-dependent neurological disorders
HUP0001237A3 (en) Methods for treating vascular disorders
EP1063990A4 (en) Therapy of estrogen-associated disorders
ZA9811507B (en) Combination effective for the treatment of impotence.
IL141263A0 (en) Methods for treatment of neurological disorders
IL145696A0 (en) Method for the treatment of neurological or neuropsychiatric disorders
EP1126850A4 (en) Treatment of disorders of the outer retina
AU1578295A (en) Use of arylcyclobutylalkylamines for the treatment of seizures and neurological disorders
PL345769A1 (en) Triazolopyridines for the treatment of thrombosis disorders
GB9926968D0 (en) Treatment of neurological disorders
PL332313A1 (en) Application of benzopyranoles in treatment of neurological disorders
ZA978640B (en) Use of 1-hydroxy-2-pyridones for the treatment of saborrheic dermatitis.
EP0981357A4 (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
ZA985818B (en) Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders.
IL135994A0 (en) Combination therapy for the treatment of aids
HUP9902802A3 (en) Pyridyl- and pyrimidyl-piperazines in the treatment of substance abuse disorders
EP0979234A4 (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
PT1011678E (en) Use of mecamylamine for the treatment of nicotine-responsive neuropsychiatric disorders
HK1044900A1 (en) Method for the treatment of neurological or neuropsychiatric disorders
AUPO504297A0 (en) Treatment of neurological disorders
AU4486797A (en) Compositions and methods useful for the treatment of neurological and mental disorders
GB9713581D0 (en) Treatment of neuropsychiatric disorders
GB2332626B (en) Medicaments for treatment of disorders of the middle ear
GB9727001D0 (en) Treatment of movement disorders